TNF and atherosclerosis: Furthermore, the anti-TNFα monoclonal antibody CNTO5048 (CNT) enhanced plasma triglycerides, VLDL, and atherosclerosis in Ldlr−/− mice (427), suggesting the use of anti-TNFα antibodies for atherosclerosis may be contraindicated.